Central nervous system health supplement
US-2022202766-A1 · Jun 30, 2022 · US
US10286025B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10286025-B2 |
| Application number | US-201615543436-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 15, 2016 |
| Priority date | Jan 15, 2015 |
| Publication date | May 14, 2019 |
| Grant date | May 14, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides a pharmaceutical composition or a food composition containing combined extracts comprising Schisandrae fructus, Eucommiae cortex and Lycii fructus as active ingredients for preventing or treating metabolic bone diseases. The composition of the present invention does not have side effects as it is a substance derived from natural sources; is effective on osteogenesis in ovariectomized mice; increases the bone content and the bone formation index of serum in real animal model; and reduces the bone resorption index so as to be useful for preventing or treating metabolic bone diseases.
Opening claim text (preview).
The invention claimed is: 1. A method for preventing or treating metabolic bone diseases comprising administering a pharmaceutical composition consisting of combined extracts coming from a mixture of Schisandrae fructus, Eucommiae cortex and Lycii fructus as active ingredients to a subject in need. 2. The method according to claim 1 wherein a weight ratio of Schisandrae fructus, Eucommiae cortex and Lycii fructus is 1˜100:1˜100:1˜100. 3. The method according to claim 1 wherein the extract is extracted with an extraction solvent selected from a group consisting of alcohol, C 1 ˜C 4 alcohol, and a mixture thereof. 4. The method according to claim 1 wherein the metabolic bone diseases are selected from a group consisting of osteoporosis, osteopenia, osteomalacia, osteodystrophy and Paget's disease. 5. The method according to claim 4 wherein osteoporosis is postmenopausal osteoporosis. 6. The method according to claim 1 wherein the metabolic bone disease is osteoporosis. 7. The method of claim 1 , wherein the pharmaceutical composition further contains one or more additives. 8. A method for preventing or improving metabolic bone diseases by administering a food composition consisting of combined extracts coming from a mixture of Schisandrae fructus, Eucommiae cortex and Lycii fructus as active ingredients to a subject in need thereof. 9. The method according to claim 8 wherein the metabolic bone disease is osteoporosis. 10. The method according to claim 9 wherein osteoporosis is postmenopausal osteoporosis. 11. The method of claim 8 , wherein the food composition further contains one or more additives. 12. The method of claim 11 , wherein the additive is a sweetener.
Schisandraceae (Schisandra family) · CPC title
Eucommiaceae (Eucommia family), e.g. hardy rubber tree · CPC title
Lycium (desert-thorn) · CPC title
Magnoliaceae (Magnolia family) · CPC title
for bone diseases, e.g. rachitism, Paget's disease · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.